|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of service | |||||
| Gross profit | |||||
| Research and development expenses | |||||
| Sales and Marketing expenses | |||||
| General and administrative expenses | |||||
| Other expenses | |||||
| Operating loss | |||||
| Change in fair value of financial instruments | |||||
| Change in fair value of marketable securities | |||||
| Change in fair value of convertible loan from shareholder | |||||
| Interest expenses | |||||
| Other finance income | |||||
| Other finance expenses | |||||
| Finance income (expenses), net | |||||
| Loss before income taxes | |||||
| Income taxes benefit | |||||
| Profit (loss) from continuing operations | |||||
| Loss from discontinued operations, net of tax | |||||
| Net loss for the year | |||||
| Basic and diluted loss per share (in U.S. dollars): | |||||
| Profit (loss) from continuing operations (in Dollars per share) | |||||
| Diluted profit (loss) from continuing operations (in Dollars per share) | |||||
| Loss from discontinued operations (in Dollars per share) | |||||
| Diluted loss from discontinued operations (in Dollars per share) | |||||
| Total basic and diluted loss per share (in Dollars per share) | |||||
| Total diluted loss per share (in Dollars per share) | |||||
| Weighted average number of issued ordinary shares (in Shares) | |||||
| Diluted weighted average number of ordinary shares (in Shares) | |||||
Loading...